Nancy King to Research Subjects
This is a "connection" page, showing publications Nancy King has written about Research Subjects.
Connection Strength
2.340
-
King NMP. Key Information in the New Common Rule: Can It Save Research Consent? J Law Med Ethics. 2019 06; 47(2):203-212.
Score: 0.693
-
King NM. There's a lot we don't know (and we ought to say so). Am J Bioeth. 2013; 13(12):20-1.
Score: 0.445
-
King NM. Benefits, harms, and motives in clinical research. Hastings Cent Rep. 2009 Jul-Aug; 39(4):3.
Score: 0.349
-
Easter MM, Henderson GE, Davis AM, Churchill LR, King NM. The many meanings of care in clinical research. Sociol Health Illn. 2006 Sep; 28(6):695-712.
Score: 0.287
-
Henderson GE, Davis AM, King NM. Vulnerability to influence: a two-way street. Am J Bioeth. 2004; 4(3):50-2; discussion W32.
Score: 0.238
-
Churchill LR, King NM, Henderson GE. Why we should continue to worry about the therapeutic misconception. J Clin Ethics. 2013; 24(4):381-6.
Score: 0.111
-
Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK. Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 2006 Jan; 62(1):239-53.
Score: 0.066
-
King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS. Consent forms and the therapeutic misconception: the example of gene transfer research. IRB. 2005 Jan-Feb; 27(1):1-8.
Score: 0.064
-
King NM. RAC oversight of gene transfer research: a model worth extending? J Law Med Ethics. 2002; 30(3):381-9.
Score: 0.052
-
Weinfurt KP, Hall MA, King NM, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 Aug 27; 361(9):916-21.
Score: 0.022
-
Churchill LR, Nelson DK, Henderson GE, King NM, Davis AM, Leahey E, Wilfond BS. Assessing benefits in clinical research: why diversity in benefit assessment can be risky. IRB. 2003 May-Jun; 25(3):1-8.
Score: 0.014